BMS‐986122

From WikiMD's Medical Encyclopedia

Revision as of 06:13, 5 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor


BMS-986122 is a chemical compound that functions as a selective positive allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor. It is being researched for its potential therapeutic applications in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia.

Chemical Structure[edit]

Chemical structure of BMS-986122

BMS-986122 is characterized by its unique chemical structure, which allows it to selectively bind to the M1 muscarinic receptor. This selectivity is crucial for its function as a PAM, enhancing the receptor's response to the endogenous neurotransmitter acetylcholine.

Mechanism of Action[edit]

BMS-986122 acts as a positive allosteric modulator, meaning it binds to a site on the M1 muscarinic receptor that is distinct from the active site. This binding enhances the receptor's response to acetylcholine without directly activating the receptor itself. By modulating the receptor's activity, BMS-986122 can potentially improve cognitive function by enhancing cholinergic signaling in the brain.

Therapeutic Potential[edit]

The M1 muscarinic receptor is implicated in various cognitive processes, and its modulation is considered a promising strategy for treating cognitive deficits associated with neurological disorders. BMS-986122, by selectively modulating this receptor, holds potential for improving symptoms in conditions such as Alzheimer's disease and schizophrenia, where cholinergic deficits are observed.

Research and Development[edit]

BMS-986122 is currently under investigation in preclinical and clinical studies to evaluate its efficacy and safety profile. The compound's ability to enhance cognitive function without the side effects associated with direct agonists of the muscarinic receptors makes it a promising candidate for further development.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=BMS‐986122&oldid=6427769"